Department of Vermont Health Access

Issue with state computer system creates federal red tape for some benefits recipients

State officials say they have sent letters to an unknown number of people asking them to change the way their names are listed with the Social Security Administration in order to receive state benefits.

Two Days Left to Sign Up for January Health Coverage through Vermont Health Connect

News Release — Department of Vermont Health Access December 13, 2016 Contact: Seán Sheehan Contact Phone Number: 802-585-6339 Contact E-mail Address: [email protected] WATERBURY, VT – Department of Vermont Health Access officials reminded Vermonters of a key health insurance deadline coming up this week. December 15 (this Thursday) is the last day to sign up with […]

New appointments include Tebbetts for agriculture, insurance lobbyist for health role

Gov.-elect Phil Scott is bringing some officials back to agencies where they have served before. He reached into the private sector for oversight of Vermont Health Connect.

Advisory board urges expanded access to hepatitis C drugs

The Department of Vermont Health Access, which administers Medicaid, will need to decide whether to go along. The drugs are widely considered some of the most expensive on the market.

Feds say they overpaid for Vermont Health Connect

The state should refund millions it received based on the assumption that every Vermonter would use the exchange, according to an inspector general’s report. The state says federal officials accepted that assumption.

VITL says it may need to borrow to pay employees

The publicly funded nonprofit that coordinates health records has $66,000 in cash on hand but needs to issue $135,000 in paychecks at the end of the month.

Scott Campaign: Phil Scott: Department of Vermont Health Access Audit Shows the Need to Modernize State Government

News Release — Phil Scott for Governor October 25, 2016 Media Contact: Ethan Latour [email protected] 802-595-3776 Phil Scott is the only candidate in this election with a government modernization plan to improve the accountability of public investments Montpelier, Vt. — Phil Scott, candidate for Governor, today issued the following statement on the report that the […]

Attorney general seeks pricing justification from 10 drug companies

A spokesperson for the Pharmaceutical Manufacturers and Researchers of America says the companies will likely send the information to the state.

Blueprint for Health director leaving this month

The director of Vermont’s Blueprint for Health will leave state government at the end of July. Dr. Craig Jones has served as the chief of the Blueprint for Health within the Department of Vermont Health Access since August 2007, according to the Human Resources Department. He made $154,647 in 2014. The spokesperson for the Department […]

Medicaid announces, then retracts decision to limit opiates

The Department of Vermont Health Access, which runs the state’s Medicaid program, said it would limit first-time prescriptions for short-acting opiates to a 10-day supply. It retracted the policy decision later Wednesday.

Judge won’t throw out Dartmouth-Hitchcock suit against Vermont

The state and federal governments asked the U.S. District Court in New Hampshire to dismiss the hospital’s lawsuit over its reimbursements under Vermont’s Medicaid program.

Barbara Cimaglio & Tom Simpatico: The state’s model for the treatment of drug addiction

Dr. Rick Barnett’s assertion that “We’ve embraced … the alleged evidence-based, maintenance medication craze” while decreasing support for psychosocial treatment, does not accurately represent what we are doing in Vermont.

Shumlin administration to ‘pause’ Medicaid cuts to hospitals

The Department of Vermont Health Access, which serves as the state’s insurance company for low-income, disabled, and elderly Vermonters, will temporarily halt cuts to Medicaid payments announced Thursday.

Medicaid by the Numbers: Vermont pays top dollar for opiate addiction drugs, antipsychotics and antidepressants

Data shows that Vermont’s Medicaid program has historically spent high sums on drugs used to treat psychiatric and substance abuse disorders. If current trends hold, the highest payouts could be for specialty drugs that treat rare diseases.